Authors: Sheeraz Shakoor Siddiqui, Muhammad Taqi Pirzada, Shams Nadeem Alam
Abstract
To determine the role of calf blood hemodialysate in the management of open wounds.
Design: Descriptive; Quasi-experimental. Methods: A total of 39 open granulating wounds of myriad etiologies were treated with calf blood hemodialysate between January 2019 and December 2024. The response to treatment was documented for: wound contraction; change of depth; complications; and, time to definitive healing/closure. Results: Mean decrease in wound length was: abdomen-0.8 cm; extremity-2.3 cm; post-abscess-4.3 cm. Mean decrease in depth was: abdomen-0.5 cm; extremity-0.2cm; post-abscess-1.4cm. Duration of healing was highest for extremity wounds (mean: 22.8 days). Four patients developed a local allergic reaction to the hemodilysate. Conclusion: Calf blood hemodialysate augments the healing process and has a positive impact on healing of open wounds.
Keywords: hemodialysate; Solcoseryl; hexosylceramide.
